REQUEST A DEMO
Total
USD $0.00
Search more companies

Smo Clinplus Co.,Ltd. (China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Smo Clinplus Co.,Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SMO ClinPlus CO.,LTD. provides site management services to both local and global companies in research development in pharmaceuticals, medical devices, and health-related products. The company provides customers with services including preliminary preparation plan, trial site startup, on-site implementation, project whole process management etc. The company was established in 2013 and is headquartered in Shanghai City, China.

Headquarters
Room 108, building 1, No. 105 Sinan Road, Huangpu District, Shanghai
Shanghai; Shanghai; Postal Code: 200001

Contact Details: Purchase the Smo Clinplus Co.,Ltd. report to view the information.

Website: http://www.smo-clinplus.com

Basic Information
Total Employees:
Purchase the Smo Clinplus Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Smo Clinplus Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Smo Clinplus Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Smo Clinplus Co.,Ltd. report to view the information.
Incorporation Date:
February 22, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
18.58%
Purchase this report to view the information.
8.05%
Purchase this report to view the information.
7.89%
Purchase this report to view the information.
7.36%
Purchase this report to view the information.
5.58%
Subsidiaries
Puris (Hangzhou) Pharmaceutical Technology Development Co., Ltd.
100%
Ruixin (Ganzhou) Pharmaceutical Technology Development Co., Ltd.
100%
Quanrong (Shanghai) Pharmaceutical Technology Development Co., Ltd.
11.93%
Company Performance
Financial values in the chart are available after Smo Clinplus Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
17.42%
Total operating revenue
18.99%
Operating profit (EBIT)
-13.28%
EBITDA
-17.58%
Net Profit (Loss) for the Period
-10.22%
Total assets
14.44%
Total equity
12.76%
Operating Profit Margin (ROS)
-5.03%
Net Profit Margin
-3.8%
Return on Equity (ROE)
-0.52%
Quick Ratio
-0.34%
Cash Ratio
-1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?